Dr. Klara Briskin, MD

Dr. Briskin practices at Neurology Pain Treatment in Elmwood Park, New Jersey.

Dr. Briskin's NPI, 1518127174, was assigned on June 16, 2008. Dr. Briskin graduated from Ross University School of Medicine in 2007. Dr. Briskin's New York license number on file is 266484.

Dr. Briskin's primary practice is Neurology Pain Treatment, at 1 Broadway, Elmwood Park, NJ 07407 in Bergen County. The practice phone is (201) 797-8333.

Dr. Briskin's primary practice is Neurology Pain Treatment in Elmwood Park, New Jersey. The medical group on file is Neurology Pain Treatment. Dmand AI also links Dr. Briskin to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Briskin practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Briskin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Briskin is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Briskin's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, epilepsy, essential tremor, fibromyalgia and chronic pain, lower back pain and migraine and chronic headache among the conditions Dr. Briskin treats.

CMS data shows 12,593 Medicare services from Dr. Briskin across 12 procedure codes in 2024, for 103 Medicare patients. Medicare paid $104,536 for them. Every service was in an office.

CMS counts 103 Medicare patients who saw Dr. Briskin in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Briskin's median patient age at 55, with 74% women.

In 2024, Dr. Briskin wrote 719 Medicare Part D claims for 105 patients. 76% of them were for generic drugs. CMS names the drug for 492 of them, across 23 drugs with 11 or more claims each, at $85,472 in total drug cost. In 2023, CMS named 643 claims across 30 drugs.

Dr. Briskin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Briskin as offering telehealth.

Dmand AI links 1 paper to Dr. Briskin in 2011. Dr. Briskin's most frequent co-authors are Krishna Chaitanya Mylavarapu, MD, Ahmad Nizam, MD and Dwithiya Krishnan Thomas, MD.

CMS Open Payments shows 1,355 general payments to Dr. Briskin from 63 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Abbvie Inc. paid the most, $18,786.

Dmand AI lists 1 award for Dr. Briskin, most recently CMS Stage 1 EHR in 2013.

Dr. Briskin graduated from Ross University School of Medicine in 2007.

Dr. Briskin is in network with 19 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.